|
rdfs:label
|
"D4-Dopaminrezeptor"@de
"Dopamine receptor D4"@en
"Dopaminski receptor D4"@sh
"Dopaminski receptor D4"@sr
"Dopaminski receptor D₄"@sr-ec
"Dopaminski receptor D₄"@sr-el
"Gene DRD4"@vi
"Receptor D4 de dopamina"@pt
"dopamin-D4-reseptor"@nn
"dopaminski receptor D4"@sl
"receptor dopaminowy D4"@pl
"дофаминовый рецептор D4"@ru
"多巴胺受体D4"@zh
|
|
skos:altLabel
|
"D(2C) dopamine receptor"@en
"D(4) dopamine receptor"@en
"D4"@ru
"D4 receptor"@sr
"D4-reseptor"@nn
"D4-рецептор"@ru
"D4DR"@sr
"DRD4"@en
"DRD4"@nn
"DRD4"@pt
"DRD4"@ru
"DRD4"@sr
"Dopaminski D4 receptor"@sr
"dopamine D4 receptor"@en
"seven transmembrane helix receptor"@en
|
|
schema:description
|
"Rezeptor für Dopamin"@de
"mammalian protein found in Homo sapiens"@en
"menneskeprotein"@nn
"protein"@sv
"protein"@id
"proteinë"@sq
"proteïne in Dopamine receptor D4"@nl
"protèin"@ace
"protéine"@fr
"білок людини"@uk
"بروتين في الإنسان العاقل"@ar
"بروتين في الإنسان العاقل"@ary
|
|
schema:dateModified
|
"2026-07-14T14:00:13+00:00"^^xsd:dateTime
|
|
schema:version
|
2517409861
|
|
wikibase:identifiers
|
6
|
|
wikibase:sitelinks
|
0
|
|
wikibase:statements
|
107
|
|
p:P129
|
wd:statement/Q308856-04D20924-49FD-49C1-BF33-903EE10A909A
|
|
wd:statement/Q308856-050FADB0-071F-4843-94BB-E45C8EACD0F7
|
|
wd:statement/Q308856-0C10F3AD-847A-48CC-BF51-2C8F08A5C749
|
|
wd:statement/Q308856-1F9C797F-DC60-48E1-86EC-37EBD5DFF81B
|
|
wd:statement/Q308856-21DC4107-E876-4D44-BED1-BD24C4299A12
|
|
wd:statement/Q308856-305F1084-0FD5-4D2F-A1ED-C9325146960F
|
|
wd:statement/Q308856-3D4CCDF2-DD88-4D4F-8577-4FF90F164025
|
|
wd:statement/Q308856-41D1F741-D212-4646-880D-74ED21B24783
|
|
wd:statement/Q308856-4223A819-EDA3-4CDA-849C-4805A6EE3535
|
|
wd:statement/Q308856-42A1835E-2C35-4421-88C4-1D09D12D3EE8
|
|
wd:statement/Q308856-4589C95B-D0CC-4615-B589-D05F0E8D51DA
|
|
wd:statement/Q308856-5799BAC8-4599-41BC-91A0-EEF8C1445637
|
|
wd:statement/Q308856-5AC30E0F-C382-47E6-BAB4-F6BB1CA003FB
|
|
wd:statement/Q308856-6127FF2A-C583-4355-996C-C7AC16600AAC
|
|
wd:statement/Q308856-642A95D2-7984-45AE-83A3-DE7D958A1AFA
|
|
wd:statement/Q308856-676A5326-981B-4B33-9CA7-3A990677314B
|
|
wd:statement/Q308856-6C598450-568D-4A82-B71A-2366E328610A
|
|
wd:statement/Q308856-6E2372C9-3EE5-4B1F-8D7D-3BF9139335D9
|
|
wd:statement/Q308856-6E3A9FF8-1D62-461B-8483-23E657F2360F
|
|
wd:statement/Q308856-795286AA-84C3-46EE-8201-F13EA388D583
|
|
wd:statement/Q308856-7FAA7A58-515F-48AF-9B00-5384F147B3A5
|
|
wd:statement/Q308856-85B275CC-955A-4EEA-8B61-2E28A6E49636
|
|
wd:statement/Q308856-8A1412E7-28BB-4353-8CF0-8E08165228C8
|
|
wd:statement/Q308856-8EAEE361-93F8-4F01-9F87-72BBA21031EE
|
|
wd:statement/Q308856-9F774750-8C54-491B-B89D-5D6D7F4D778A
|
|
wd:statement/Q308856-A18A669F-DAFE-443D-B47F-63E99A0CB232
|
|
wd:statement/Q308856-A6138465-29C3-44EA-A29A-5AE374241A99
|
|
wd:statement/Q308856-AB1D17E8-CF3F-4614-A852-CE178E1C2D1F
|
|
wd:statement/Q308856-B3D9CEFE-56A8-4EBA-9A84-E30C6595CB3B
|
|
wd:statement/Q308856-BD74D8C2-B9C3-4727-B446-EAFD60324E53
|
|
wd:statement/Q308856-BDA1A755-BEEE-4B74-96CA-931A19258EB8
|
|
wd:statement/Q308856-BE8CAB6A-CA20-4F55-A45B-64D385FFAD7E
|
|
wd:statement/Q308856-C2BAD043-9562-4BDA-B6E1-79A24C28930A
|
|
wd:statement/Q308856-CEF9C9F2-1289-4558-BD7D-041AC4E8632A
|
|
wd:statement/Q308856-D80F08E4-6A90-43BC-AB4F-355292CF9B27
|
|
wd:statement/Q308856-DCBB6FFC-C7D2-4F9B-B3B6-953C3F70F8BB
|
|
wd:statement/Q308856-E0C3A81F-BFDD-42E1-BC6F-55D271F19EF6
|
|
wd:statement/Q308856-EEF05445-6CAE-4FE7-B876-D0480814C8DB
|
|
wd:statement/Q308856-F176BA13-BB4E-495E-B52B-8C5F44ADB8E0
|
|
wd:statement/Q308856-F750E05B-BF07-4F93-8BF8-E3901B1EAB55
|
|
wd:statement/Q308856-F8031CCD-E318-4CC3-8501-42E66210DE63
|
|
p:P2888
|
wd:statement/Q308856-157661A5-0157-47CB-A4FC-92FBEDDB778E
|
|
p:P2892
|
wd:statement/Q308856-9E4CFCD5-9B07-4978-A9AD-FE4DD5E8000B
|
|
p:P31
|
wd:statement/Q308856-322C2E54-9F83-49D7-B433-1BB49687B455
|
|
p:P352
|
wd:statement/q308856-B7C7A6A4-6D8F-40BD-A9D5-48A4558FE3FA
|
|
p:P361
|
wd:statement/Q308856-A6A7560C-4F26-48D9-86CA-51E41BE88334
|
|
wd:statement/Q308856-DACA7770-0361-4989-B0C5-1F433C2F7D54
|
|
p:P527
|
wd:statement/Q308856-F058EF79-AFAA-4BE6-BDF5-1178C693ABB6
|
|
p:P637
|
wd:statement/Q308856-3F32F99D-8135-4BCD-93FF-53CFB1013127
|
|
p:P646
|
wd:statement/Q308856-E8BD0E46-15BD-4C1F-ACF2-BDE5B3FD8859
|
|
p:P680
|
wd:statement/Q308856-1952EBB3-DF85-43DD-90FB-E6420DB0C1CD
|
|
wd:statement/Q308856-210ADA6B-DE91-4311-A5A4-05C80E0F8914
|
|
wd:statement/Q308856-2A2844F8-F250-4B2D-B724-EFC2C9B540E2
|
|
wd:statement/Q308856-34A0EC7A-F13A-4D29-ADCC-8EB0BC0EBC0A
|
|
wd:statement/Q308856-42B8BA3D-9726-49B7-85DF-2B73DCC1A9B6
|
|
wd:statement/Q308856-5B86EDF3-71CB-4B97-85C0-C6FBECA2EB3D
|
|
wd:statement/Q308856-7935D0BC-BD0E-400E-AAB9-D466D7D240F6
|
|
wd:statement/Q308856-827E47CC-2E5F-4656-BF4B-CF90834A6D6A
|
|
wd:statement/Q308856-85BB28B3-9969-4C48-A0B4-994BC304D233
|
|
wd:statement/Q308856-977F5E02-2943-42E2-97AC-5C2F24F79BFC
|
|
wd:statement/Q308856-9F31A869-96AC-4C1F-8E39-D48146E9E9FB
|
|
wd:statement/Q308856-CC79DF7A-3D5F-4C1E-B69B-6AD868DA853A
|
|
wd:statement/Q308856-DF30C221-2EAC-47D6-BCF3-ECD442FE8FAD
|
|
wd:statement/Q308856-E12E1D87-155D-47A5-A37A-21330E4A92C0
|
|
wd:statement/Q308856-FA0D2593-B46C-4343-8D93-EB3EA090628C
|
|
p:P681
|
wd:statement/Q308856-28926677-2C82-488D-9F63-B3C84A0DB2F8
|
|
wd:statement/Q308856-512E2580-DBC1-4A91-8ED2-7D3B8BB31DC5
|
|
wd:statement/Q308856-55828C9F-BE6D-4A81-8FF9-81DFE49F53D6
|
|
wd:statement/Q308856-6849E198-2911-4FC0-A136-C8723A3D4343
|
|
wd:statement/Q308856-8429CF17-1187-416A-BE21-93D6768E0DFD
|
|
wd:statement/Q308856-AB1B209A-8EF3-45EE-8F11-D0A51157C7BD
|
|
wd:statement/Q308856-ECB84425-088C-40E3-8D9A-1E407FC93096
|
|
wd:statement/Q308856-F83B377F-9295-450B-B6A8-A84F3F62CCD9
|
|
p:P682
|
wd:statement/Q308856-06C580EE-F795-4506-8ACF-E35B72184DC6
|
|
wd:statement/Q308856-10EC3F31-093C-4C5C-B689-0FCFB326080C
|
|
wd:statement/Q308856-1298C1DA-CC50-46F7-8410-20A2647EB8E0
|
|
wd:statement/Q308856-1B1C199A-4158-4B33-B8F4-0128F068E21A
|
|
wd:statement/Q308856-24D54621-16E1-424E-BD8E-F55BB9D19F79
|
|
wd:statement/Q308856-2BE795DD-F005-4BF0-8526-39A2F9871A7E
|
|
wd:statement/Q308856-5039C4DA-BF2D-4C9D-AD15-9304D59D53DF
|
|
wd:statement/Q308856-520B6CF0-EFAB-4AFB-A04F-C0FA3851CC28
|
|
wd:statement/Q308856-5277731F-C84A-485E-BADF-B90A2CD12A24
|
|
wd:statement/Q308856-5D55A270-EB1A-4485-970C-CD0C9F9603DB
|
|
wd:statement/Q308856-6D2DC78B-A76F-4252-A2C1-F095B8DBBE5B
|
|
wd:statement/Q308856-7313FC6B-9FDA-4195-B016-F8D993276B46
|
|
wd:statement/Q308856-7541C1F0-8A98-4468-9AB4-21C044CA3726
|
|
wd:statement/Q308856-7CD44694-3AC7-4FCA-AC91-6AFA21F5F521
|
|
wd:statement/Q308856-8BD1CCEA-797B-4363-A423-714217F48069
|
|
wd:statement/Q308856-920BCF4B-82BF-493D-B547-A42385F7735E
|
|
wd:statement/Q308856-985B16DA-B310-41BE-9529-266A323C202A
|
|
wd:statement/Q308856-9A19A4E8-F722-44F7-9593-0AD44AC55E87
|
|
wd:statement/Q308856-A0B709B1-F207-4395-BF0A-0A5962D9D470
|
|
wd:statement/Q308856-AF744257-C9BA-4B17-BD1B-77CC6814B8BF
|
|
wd:statement/Q308856-C38AF8AD-F325-45A4-AD10-CF0F5089D2EB
|
|
wd:statement/Q308856-C5E34146-3C5E-4210-81CB-0D3B35A81FBE
|
|
wd:statement/Q308856-C9DEC3E7-CD5F-449C-B19B-9C3238D9BF33
|
|
wd:statement/Q308856-CABAB7A1-FF9E-4194-8119-1789FAEFA525
|
|
wd:statement/Q308856-CCB4A1A2-4BFB-4B18-812A-0AF61488BE87
|
|
wd:statement/Q308856-D51A5A44-2008-4C86-9D6A-3C7BB919F251
|
|
wd:statement/Q308856-D7DBC12E-8A67-4DE4-90D6-06D16EE996A5
|
|
wd:statement/Q308856-F3CCB28A-F10C-4AE6-A413-718C2BDC4BBC
|
|
wd:statement/Q308856-FB89D20D-4FAD-44DF-9C1A-61B1786DBB1F
|
|
p:P692
|
wd:statement/Q308856-6E676CF8-E48E-412C-B317-3FE705E6C197
|
|
p:P702
|
wd:statement/Q308856-23E9C5EB-2272-484A-8484-70C633E7C7A3
|
|
p:P703
|
wd:statement/Q308856-27FC04F2-E376-463C-88B3-5A25BBCF1E25
|
|
p:P705
|
wd:statement/Q308856-074EF699-2E08-433A-BFAE-FA2F872F2BEE
|
|
wd:statement/Q308856-DD5D0161-CC68-42AC-8366-D07FCA365449
|
|
p:direct-normalized/P352
|
<http://purl.uniprot.org/uniprot/P21917>
|
|
p:direct-normalized/P637
|
<http://purl.uniprot.org/refseq/NP_000788>
|
|
wdt:P129
|
eticlopride
|
|
pimozide
|
|
levosulpiride
|
|
dopamine
|
|
droperidol
|
|
trifluoperazine
|
|
clozapine
|
|
zotepine
|
|
fenoldopam
|
|
prochlorperazine
|
|
haloperidol
|
|
quinpirole
|
|
apomorphine
|
|
thioridazine hydrochloride
|
|
bromocriptine mesylate
|
|
chlorpromazine hydrochloride
|
|
pergolide mesylate
|
|
promazine hydrochloride
|
|
spiperone
|
|
chlorpromazine
|
|
(6S)-rotigotine
|
|
bromocriptine
|
|
piribedil
|
|
pergolide
|
|
sertindole
|
|
cabergoline
|
|
lisuride
|
|
A-412997
|
|
ABT-670
|
|
(+)-butaclamol
|
|
loxapine
|
|
L745870
|
|
perospirone
|
|
5-chloro-2-methoxy-4-(methylamino)-N-(2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)benzamide
|
|
PF-592379
|
|
roxindole
|
|
sonepiprazole
|
|
terguride
|
|
WAY-100635
|
|
wdt:P2888
|
<http://purl.uniprot.org/uniprot/P21917>
|
|
wdt:P2892
|
"C0114835"
|
|
wdt:P31
|
protein
|
|
wdt:P352
|
"P21917"
|
|
wdt:P361
|
dopamine D4 receptor
|
|
GPCR, rhodopsin-like, 7TM, protein family
|
|
wdt:P527
|
GPCR, rhodopsin-like, 7TM
|
|
wdt:P637
|
"NP_000788"
|
|
wdt:P646
|
"/m/06cyr8"
|
|
wdt:P680
|
metal ion binding
|
|
potassium channel regulator activity
|
|
identical protein binding
|
|
signal transducer activity
|
|
G protein-coupled receptor activity
|
|
SH3 domain binding
|
|
dopamine binding
|
|
dopamine neurotransmitter receptor activity, coupled via Gi/Go
|
|
dopamine neurotransmitter receptor activity
|
|
G protein-coupled serotonin receptor activity
|
|
epinephrine binding
|
|
norepinephrine binding
|
|
protein binding
|
|
neurotransmitter receptor activity
|
|
wdt:P681
|
dendrite
|
|
integral component of membrane
|
|
membrane
|
|
integral component of plasma membrane
|
|
postsynapse
|
|
glutamatergic synapse
|
|
plasma membrane
|
|
wdt:P682
|
inhibitory postsynaptic potential
|
|
chemical synaptic transmission
|
|
adult locomotory behavior
|
|
cellular calcium ion homeostasis
|
|
G protein-coupled receptor signaling pathway
|
|
negative regulation of protein secretion
|
|
response to amphetamine
|
|
behavioral response to cocaine
|
|
dopamine metabolic process
|
|
behavioral fear response
|
|
fear response
|
|
arachidonic acid secretion
|
|
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
|
|
regulation of circadian rhythm
|
|
rhythmic process
|
|
regulation of dopamine metabolic process
|
|
adenylate cyclase-inhibiting dopamine receptor signaling pathway
|
|
dopamine receptor signaling pathway
|
|
positive regulation of sodium:proton antiporter activity
|
|
positive regulation of kinase activity
|
|
response to histamine
|
|
behavioral response to ethanol
|
|
positive regulation of dopamine uptake involved in synaptic transmission
|
|
negative regulation of voltage-gated calcium channel activity
|
|
G protein-coupled serotonin receptor signaling pathway
|
|
regulation of postsynaptic neurotransmitter receptor internalization
|
|
signal transduction
|
|
social behavior
|
|
wdt:P692
|
<http://commons.wikimedia.org/wiki/Special:FilePath/PBB%20GE%20DRD4%20208215%20x%20at%20fs.png>
|
|
wdt:P702
|
DRD4
|
|
wdt:P703
|
man
|
|
wdt:P705
|
"ENSP00000176183"
|
|
"ENSP00000478431"
|
